Complement-mediated virus infectivity neutralisation by HLA antibodies is associated with sterilising immunity to SIV challenge in the macaque model for HIV/AIDS.
Sterilising immunity is a desired outcome for vaccination against human immunodeficiency virus (HIV) and has been observed in the macaque model using inactivated simian immunodeficiency virus (SIV). This protection was attributed to antibodies specific for cell proteins including human leucocyte ant...
Main Authors: | Mark Page, Ruby Quartey-Papafio, Mark Robinson, Mark Hassall, Martin Cranage, James Stott, Neil Almond |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3925162?pdf=render |
Similar Items
-
Heterologous protection elicited by candidate monomeric recombinant HIV-1 gp120 vaccine in the absence of cross neutralising antibodies in a macaque model
by: Page Mark, et al.
Published: (2012-07-01) -
P11-10. Modulation of intestinal T cells following infection of macaques with live attenuated and conditionally replication-competent SIV
by: Berkhout B, et al.
Published: (2009-10-01) -
Replication kinetics and persistence of a conditionally live attenuated SIV (SIVrtTA) <it>in vivo </it>confers protection against SIVmac239 wild-type challenge in a rhesus macaque model
by: Cranage Martin, et al.
Published: (2009-09-01) -
Identification of neutralising determinants in protection against HIV-1
by: Hassall, Mark
Published: (2010) -
Role of complement and antibodies in controlling infection with pathogenic simian immunodeficiency virus (SIV) in macaques vaccinated with replication-deficient viral vectors
by: Strasak Alexander, et al.
Published: (2009-06-01)